These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 30585270)
1. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression. Wang Y; Zhou Z; Wang X; Zhang X; Chen Y; Bai J; Di W Int J Biol Sci; 2018; 14(14):2073-2082. PubMed ID: 30585270 [TBL] [Abstract][Full Text] [Related]
2. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53. Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164 [TBL] [Abstract][Full Text] [Related]
3. TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10. Tan P; Ye Y; He L; Xie J; Jing J; Ma G; Pan H; Han L; Han W; Zhou Y PLoS Biol; 2018 Nov; 16(11):e3000051. PubMed ID: 30408026 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway. Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X Gene; 2019 May; 698():50-60. PubMed ID: 30822475 [TBL] [Abstract][Full Text] [Related]
5. Tripartite Motif-Containing Protein 59 (TRIM59) Promotes Epithelial Ovarian Cancer Progression via the Focal Adhesion Kinase(FAK)/AKT/Matrix Metalloproteinase (MMP) Pathway. Zhang P; Zhang H; Wang Y; Zhang P; Qi Y Med Sci Monit; 2019 May; 25():3366-3373. PubMed ID: 31062766 [TBL] [Abstract][Full Text] [Related]
6. TRIM59 is a key regulator of growth and migration inrenal cell carcinoma. Hu SH; Zhao MJ; Wang WX; Xu CW; Wang GD Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):68-74. PubMed ID: 28719348 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of tripartite motif protein 59 inhibits proliferation, migration and invasion in breast cancer cells. Zhang Y; Yang WB Biomed Pharmacother; 2017 May; 89():462-467. PubMed ID: 28249247 [TBL] [Abstract][Full Text] [Related]
8. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway. Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983 [TBL] [Abstract][Full Text] [Related]
9. TRIM59 knockdown inhibits cell proliferation by down-regulating the Wnt/β-catenin signaling pathway in neuroblastoma. Chen G; Chen W; Ye M; Tan W; Jia B Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30389710 [TBL] [Abstract][Full Text] [Related]
10. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway. Wu C; Shang XQ; You ZP; Jin QF; Zhang YL; Zhou Y; Zhang YZ; Shi K Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):2. PubMed ID: 32744597 [TBL] [Abstract][Full Text] [Related]
11. Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Lokman NA; Elder AS; Ween MP; Pyragius CE; Hoffmann P; Oehler MK; Ricciardelli C Oncotarget; 2013 Aug; 4(8):1199-211. PubMed ID: 23945256 [TBL] [Abstract][Full Text] [Related]
12. Tripartite motif containing 59 (TRIM59) promotes esophageal cancer progression via promoting MST4 expression and ERK pathway. Liu G; Song J; Zhao Y; Zhang L; Qin J; Cui Y J Recept Signal Transduct Res; 2020 Oct; 40(5):471-478. PubMed ID: 32340525 [No Abstract] [Full Text] [Related]
13. Knockdown of Tripartite-59 (TRIM59) Inhibits Cellular Proliferation and Migration in Human Cervical Cancer Cells. Aierken G; Seyiti A; Alifu M; Kuerban G Oncol Res; 2017 Mar; 25(3):381-388. PubMed ID: 27662486 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of tripartite motif 59 and its diagnostic utility in benign bowel diseases and colorectal cancer. Dahpy MA; Salama RHM; Kamal AA; El-Deek HE; AbdelMotaleb AA; Abd-El-Rehim AS; Hassan EA; Alsanory AA; Saad MM; Ali M J Biochem Mol Toxicol; 2022 Jul; 36(7):e23065. PubMed ID: 35377964 [TBL] [Abstract][Full Text] [Related]
15. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis. Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252 [TBL] [Abstract][Full Text] [Related]
16. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B. Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the oncogenic activity of the novel TRIM59 gene in mouse cancer models. Valiyeva F; Jiang F; Elmaadawi A; Moussa M; Yee SP; Raptis L; Izawa JI; Yang BB; Greenberg NM; Wang F; Xuan JW Mol Cancer Ther; 2011 Jul; 10(7):1229-40. PubMed ID: 21593385 [TBL] [Abstract][Full Text] [Related]
18. TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway. Liu Y; Dong Y; Zhao L; Su L; Diao K; Mi X Mol Carcinog; 2018 Dec; 57(12):1792-1802. PubMed ID: 30175868 [TBL] [Abstract][Full Text] [Related]
19. TRIM59 promotes cell proliferation, migration and invasion in human hepatocellular carcinoma cells. Sun G; Sui X; Han D; Gao J; Liu Y; Zhou L Pharmazie; 2017 Nov; 72(11):674-679. PubMed ID: 29442042 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of tripartite motif-59 inhibits the malignant processes in human colorectal cancer cells. Wu W; Chen J; Wu J; Lin J; Yang S; Yu H Oncol Rep; 2017 Oct; 38(4):2480-2488. PubMed ID: 28849218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]